XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 1,007 $ 17,492,083 $ (18,102,618) $ (609,528)
Balance (in shares) at Dec. 31, 2017 3,051,538      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 0 7,645 0 7,645
Capitalized offering costs 0 (44,000) 0 (44,000)
Issuance of common stock, net of issuance costs $ 96 801,798 0 801,894
Issuance of common stock, net of issuance costs (in shares) 289,605      
Warrant costs associated with stock issuance $ 0 342,105 0 342,105
Net income (loss) 0 0 (1,305,723) (1,305,723)
Balance at Jun. 30, 2018 $ 1,103 18,599,631 (19,408,341) (807,607)
Balance (in shares) at Jun. 30, 2018 3,341,143      
Balance at Mar. 31, 2018 $ 1,100 18,555,004 (18,840,510) (284,406)
Balance (in shares) at Mar. 31, 2018 3,333,398      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 0 630 0 630
Issuance of common stock, net of issuance costs $ 3 43,997 0 44,000
Issuance of common stock, net of issuance costs (in shares) 7,745      
Net income (loss) $ 0 0 (567,831) (567,831)
Balance at Jun. 30, 2018 $ 1,103 18,599,631 (19,408,341) (807,607)
Balance (in shares) at Jun. 30, 2018 3,341,143      
Balance at Dec. 31, 2018 $ 1,128 19,311,529 (21,013,174) (1,700,517)
Balance (in shares) at Dec. 31, 2018 3,417,187      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 0 2,773,451 0 2,773,451
Issuance of common stock, net of issuance costs $ 16 749,984 0 750,000
Issuance of common stock, net of issuance costs (in shares) 48,930      
Issuance of common stock for antidilution $ 32 (32) 0 0
Issuance of common stock for antidilution (in shares) 97,960      
Issuance of common stock for convertible debt $ 3 32,950 0 32,953
Issuance of common stock for convertible debt (in shares) 9,683      
Issuance of common stock from 401K match $ 2 25,241 0 25,243
Issuance of common stock from 401K match (in shares) 4,549      
Equity from merger transaction $ 528 15,793,110 0 15,793,638
Equity from merger transaction (in shares) 1,599,178      
Net income (loss) $ 0 0 2,930,847 2,930,847
Balance at Jun. 30, 2019 $ 1,709 38,686,233 (18,082,327) 20,605,615
Balance (in shares) at Jun. 30, 2019 5,177,487      
Balance at Mar. 31, 2019 $ 1,707 38,642,411 (14,196,475) 24,447,643
Balance (in shares) at Mar. 31, 2019 5,172,938      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 0 18,580 0 18,580
Issuance of common stock from 401K match $ 2 25,242 0 25,244
Issuance of common stock from 401K match (in shares) 4,549      
Net income (loss) $ 0 0 (3,885,852) (3,885,852)
Balance at Jun. 30, 2019 $ 1,709 $ 38,686,233 $ (18,082,327) $ 20,605,615
Balance (in shares) at Jun. 30, 2019 5,177,487